Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bradford Hoppe

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of Urology|January 15, 2016
Reply by AuthorBradford Hoppe
Current Oncology Reports|April 3, 2017
Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of RadiotherapyAndrea Riccardo Filippi, Mario Levis, Rahul Parikh, et al.
Rare Tumors|July 21, 2022
Very low-dose radiation therapy for management of inflammatory myofibroblastic tumor of the lungNimeh Najjar, Hamel Patel, Scott Steinberg, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 30, 2020
A comparative study of prostate PTV margins for patients using hydrogel spacer or rectal balloon in proton therapyZhong Su, Randal Henderson, Romaine Nichols, et al.
Oncology (Williston Park, N.Y.)|September 6, 2011
Proton therapy for prostate cancerBradford Hoppe, Randal Henderson, William M Mendenhall, et al.
Plos One|July 9, 2020
Patient preferences for reducing bowel adverse events following prostate radiotherapyMark V Mishra, Winter Maxwell Thayer, Ellen Janssen, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 18, 2009
Patterns and incidence of neural invasion in patients with cancers of the paranasal sinusesZiv Gil, Diane L Carlson, Amar Gupta, et al.
Physics in Medicine and Biology|January 11, 2019
PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boostZhong Su, Zuofeng Li, Randal Henderson, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2020
Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic ExperienceLeyla Bojanini, Liuyan Jiang, Alexander J Tun, et al.
Pediatric Blood & Cancer|July 28, 2023
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphomaSharon M Castellino, Lisa Giulino-Roth, Paul Harker-Murray, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Urology|January 15, 2016
Reply by AuthorBradford Hoppe
Current Oncology Reports|April 3, 2017
Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of RadiotherapyAndrea Riccardo Filippi, Mario Levis, Rahul Parikh, et al.
Rare Tumors|July 21, 2022
Very low-dose radiation therapy for management of inflammatory myofibroblastic tumor of the lungNimeh Najjar, Hamel Patel, Scott Steinberg, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 30, 2020
A comparative study of prostate PTV margins for patients using hydrogel spacer or rectal balloon in proton therapyZhong Su, Randal Henderson, Romaine Nichols, et al.
Oncology (Williston Park, N.Y.)|September 6, 2011
Proton therapy for prostate cancerBradford Hoppe, Randal Henderson, William M Mendenhall, et al.
Plos One|July 9, 2020
Patient preferences for reducing bowel adverse events following prostate radiotherapyMark V Mishra, Winter Maxwell Thayer, Ellen Janssen, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 18, 2009
Patterns and incidence of neural invasion in patients with cancers of the paranasal sinusesZiv Gil, Diane L Carlson, Amar Gupta, et al.
Physics in Medicine and Biology|January 11, 2019
PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boostZhong Su, Zuofeng Li, Randal Henderson, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2020
Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic ExperienceLeyla Bojanini, Liuyan Jiang, Alexander J Tun, et al.
Pediatric Blood & Cancer|July 28, 2023
Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphomaSharon M Castellino, Lisa Giulino-Roth, Paul Harker-Murray, et al.
Pageof 2